Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. ( (AU:IBX) ) has issued an announcement.
Imagion Biosystems Limited reported a significant financial loss for the half-year ending June 30, 2025, with no revenue from ordinary activities and an 8.8% increase in losses compared to the previous period. The company did not declare any dividends, and its net tangible assets per ordinary security decreased, reflecting ongoing financial challenges.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited operates in the biotechnology industry, focusing on the development of medical imaging technology. The company is primarily engaged in creating non-radioactive diagnostic imaging solutions aimed at improving the early detection of cancer.
Average Trading Volume: 4,854,766
Technical Sentiment Signal: Sell
Current Market Cap: A$3.94M
Learn more about IBX stock on TipRanks’ Stock Analysis page.